SEC Form 4 · accession 0001162194-18-000043
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicolas Barthelemy
Director
Period of report
Mar 23, 2018
Accepted (ET)
Mar 26, 2018 · 8:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 23, 2018 | M | 2,500 | $0.00 | A | 26,362 | I | The Barthelemy 2001 Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Mar 23, 2018 | M | 2,500 | D | Mar 23, 2018 | — | Common Stock | 2,500 | 7,500 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
- F2On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units, of which 25% of the total number of shares underlying the Restricted Stock Units have vested and will continue to vest on each anniversary after the date of grant on the same day of the month as the date of grant until fully vested, subject to continued service as a director through each such date.